Nordictropin 12iu Hgh Injectable Human Growth Hormone Supplements

Quick Info :

Norditropin^® (somatropin) injection is a recombinant human growth indicated for treatment of pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone (GH), short stature associated with Turner syndrome, short stature born small for gestational age (SGA) with no catch-up growth by age 2 to 4 years, Idiopathic Short Stature (ISS), and growth failure due to Prader-Willi Syndrome and replacement of endogenous GH in adults with growth hormone deficiency.

HGH Function:

The Human Growth Hormone serves several vital and essential functions in the body:
• HGH plays a crucial role in increasing the height among children and adolescents.
• HGH increases calcium preservation, and augments bone mineralization.
• It enhances muscle mass.
• Promotes lipolysis (fat break down) and gluconeogenesis (production of glucose from amino acids) in the liver.
• Reduces the absorption of glucose by the liver
• Encourages protein production
• It plays a crucial role in cell reproduction and thereby stimulates the growth of various body tissues.
• Stimulates the defense and immune mechanisms of the body
• Helps prevent premature ageing and preserves youthfulness

Nordictropin Dosage & Administration:

Administer by subcutaneous injection to the back of upper arm, abdomen, buttock, or thigh with regular rotation of injection sites

Pediatric Dosage - divide the calculated weekly dosage into equal doses given either 6, or 7 days per week

GHD: 0.17 mg/kg/week to 0.24 mg/kg/week

Noonan Syndrome: Up to 0.46 mg/kg/week

Turner Syndrome: Up to 0.47 mg/kg/week

SGA: Up to 0.47 mg/kg/week

ISS: Up to 0.47 mg/kg/week

Prader-Willi Syndrome: 0.24 mg/kg/week

Adult Dosage: Either of the following two dosing regimens may be used:

Non-weight based dosing: Initiate with a dose of approximately 0.2 mg/day (range, 0.15 mg/day-0.3 mg/day) and increase the dose every 1-2 months by increments of approximately 0.1 mg/day-0.2 mg/day, according to individual patient requirements

Weight-based dosing (Not recommended for obese patients): Initiate at 0.004 mg/kg daily and increase the dose according to individual patient requirements to a maximum of 0.016 mg/kg daily

How to Stock the Norditcropin:

Nordictropin products must be refrigerated (36°F to 46°F) prior to first use.

Do not freeze and avoid direct light. After first injection, Norditropin pens can either be stored outside of the refrigerator (up to 77°F) for use within 3 weeks, or in the refrigerator (between 36°F and 46°F) for use within 4 weeks.